Internship
Intern – HR
Talent Development
Posted on 3/2/2024
Develops therapeutics for eye conditions
Irvine, CA, USA
Tarsus Pharmaceuticals, Inc. focuses on developing innovative therapeutics for various eye conditions, including an FDA-approved treatment for Demodex blepharitis called XDEMVY™, utilizing advanced pharmaceutical formulations and scientific research to address high unmet medical needs in eye care. The main technologies used in their product include advanced pharmaceutical formulations and scientific research.
Company Stage
IPO
Total Funding
$610.6M
Headquarters
Irvine, California
Founded
2017